Risk of arterial and venous occlusive events in chronic myeloid leukemia patients treated with new generation BCR-ABL tyrosine kinase inhibitors: a systematic review and meta-analysis

Carlos Graux (Contributor)
Christian Chatelain (Contributor)
Francois Mullier (Contributor)
Helene Haguet (Contributor)
Jean-Michel Dogne (Contributor)
Jonathan Douxfils (Contributor)

Dataset

1 Article

1 results

2016
Risk of arterial and venous occlusive events in chronic myeloid leukemia patients treated with new generation BCR-ABL tyrosine kinase inhibitors: a systematic review and meta-analysis
Haguet, H., Douxfils, J., Mullier, F., Chatelain, C., Graux, C. & Dogné, J. M., 2016, In: Expert Opinion On Drug Safety. p. 1-8 8 p.
Research output: Contribution to journal › Article › peer-review